Loss of [125I]-pindolol binding to β-adrenoceptors on rat nodose ganglion after chronic isoprenaline treatment

Journal of the Autonomic Nervous System

Volumn 60, Issue 1-2, 1996, Pages 12-16

  Watkins, Dianne J ^a   Lawrence, Andrew J ^a   Lewis, Stephen J ^b   Jarrott, Bevyn ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Autoradiography; Desensitization; Down regulation; Isoprenaline; Nodose ganglion; Pindolol; Rat; Adrenoceptor

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; ATENOLOL; BETA ADRENERGIC RECEPTOR; ISOPRENALINE; PINDOLOL; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; CONTROLLED STUDY; MALE; NODOSE GANGLION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; SUBCUTANEOUS DRUG ADMINISTRATION; ANIMAL; BINDING COMPETITION; DOWN REGULATION; DRUG EFFECT; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BINDING, COMPETITIVE; DOWN-REGULATION; ISOPROTERENOL; MALE; NODOSE GANGLION; PINDOLOL; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA;

EID: 0030603844     PISSN: 01651838     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-1838(96)00025-2     Document Type: Article

References (30)

1. 1-adrenoceptors, Life Sci., 30 (1982) 945-952.
2. 125]-iodopindolol, a new highly selective radioiodinated β-adrenergic receptor antagonist: measurement of β-receptors on intact rat astrocytoma cells, J. Cycl. Nucl. Res., 6 (1980) 297-307.
3. [3] Benovic, J.L., Strasser, R.H., Caron, M.G. and Lefkowitz, R.J., β-adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor, Proc. Nat. Acad. Sci. U.S.A., 83 (1986) 2797-2801.
4. 2-adrenergic receptor, J. Biol. Chem., 264 (1989) 16786-16792.
5. 1-receptor down-regulation in heart failure, Cir. Res., 59 (1986) 297-309.
6. [6] Christensen, N.J. and Videbaek, J., Plasma catecholamines and carbohydrate metabolism in patients with acute myocardial infarction, J. Clin. Invest., 54 (1974) 278-286.
7. [7] Francis, G.S., Goldsmith, S.R., Ziesche, S.M. and Cohn, J.N., Response of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failure. Am. J. Cardiol., 49 (1982) 1152-1156.
8. [8] Hadcock, J.R. and Malbon, C.C., Down-regulation of β-adrenergic receptors: agonist-induced reduction in receptor mRNA levels, Proc. Natl. Acad. Sci. U.S.A., 85 (1988) 5021-5025.
9. 2-adrenergic receptor are involved in distinct pathways of receptor desensitisation, J. Biol. Chem., 264 (1989) 12657-12665.
10. [10] Kompa, A.R., Molenaar, P.M. and Summers, R.J., Effect of chemical sympathectomy on ( - )-isoprenaline-induced changes in cardiac β-adrenoceptor subytpes in the guinea-pig and rat, J. Auton. Pharmacol., 14 (1994) 411-423.
11. [11] Kowalski, M.T., Hadworth, D., Lu, X., Thomson, D.S. and Barnett, D.B., Comparison of the effects of xamoterol and isoprenaline on rat cardiac β-adrenoceptors: studies of function and regulation, Br. J. Pharmacol., 99 (1990) 27-30.
12. [12] Lawrence, A.J., Watkins, D.J. and Jarrott, B., Visualisation of β-adrenoceptor binding sites on human inferior vagal ganglia and their axonal transport along the rat vagus nerve, J. Hypertens., 13 (1995) 631-635.
13. [13] Lohse, M.J., Benovic, J.L., Codina, J., Caron, M.G. and Lefkowitz, R.J., β-Arrestin: A protein that regulates β-adrenergic receptor function, Science, 248 (1990) 1547-1550.
14. 2-receptor-mediated responses, Br. J. Pharmacol., 112 (1994) 595-603.
15. [15] McPherson, G.A., Molenaar, P. and Malta, E., The affinity and efficacy of naturally occurring catecholamines at β-adrenoceptor subtypes, J. Pharm. Pharmacol., 37 (1985) 498-499.
16. [16] Molenaar, P., Smolich, J.J., Russell, F.D., McMartin, L.R. and Summers, R.J., Differential regulation of β-1 and β-2 adrenoceptors in guinea-pig atrioventricular conducting system after chronic ( - )-isoproterenol infusion, J. Pharmacol. Exp. Ther., 255 (1990) 393-400.
17. [17] Munch, P.A., Thoren, P.N. and Brown, A.M., Dual effects of norepinephrine and mechanisms of baroreceptor stimulation, Cir. Res., 61 (1987) 409-419.
18. [18] Murphree, S.S. and Saffitz, J.E., Distribution of β-adrenergic receptors in failing human myocardium. Circulation, 79 (1989) 1214-1225.
19. [19] Nanoff, C., Ströher, M., Haschkowitz, H., Schütz, W. and Pittner, H., Desensitization pattern of cardiac β-adrenoceptor subtypes by prolonged in vivo infusion of pindolol and celiprolol in rats, Bas. Res. Cardiol., 85 (1990) 88-95.
20. 2-adrenergic receptors after down-regulation or irreversible blockade, Mol. Pharmacol., 30 (1986) 104-111.
21. [21] Ordway, G.A., Gambarana, C. and Frazer, A., Quantitative autoradiography of central beta adrenoceptor subtypes: comparison of the effects of chronic treatment with desipramine or centrally administered l-isoproterenol, J. Pharmacol. Exp. Then, 247 (1988) 379-389.
22. [22] Russell, F.D., Kompa, A.R., Molenaar, P. and Summers, R.J., Regulation of β-adrenoceptors in the guinea-pig sinoatrial node, Naunyn Schmiedeberg's Arch. Pharmacol. 349 (1994) 463-472.
23. 2-adrenoceptors, J. Autonom. Pharmacol., In Press.
24. [24] Snavely, M.D., Ziegler, M.G. and Insel, P.A., Subtype-selective down-regulation of rat renal cortical α-and β-adrenergic receptors by catecholamines, Endocrinology, 117 (1985) 2182-2189.
25. [25] Stadel, J.M., Strulovici, B., Nambi, P., Lavin, T.N., Briggs, M.M., Caron, M.G. and Lefkowitz, R.J., Desensitisation of the β-adrenergic receptor of frog erythrocytes. Recovery and characterisation of the down-regulated receptors in sequestered vesicles, J. Biol. Chem., 258 (1983) 3032-3038.
26. [26] Strasser, R.H., Stiles, G.L. and Lefkowitz, R.J., Translocation and uncoupling of the β-adrenergic receptor in rat lung after catecholamine promoted desensitization in vivo, Endocrinology, 115 (1984) 1392-1400.
27. [27] Strulovici, B., Stadel, J.M. and Lefkowitz, R.J., Functional integrity of desensitized β-adrenoceptors receptors, J. Biol. Chem., 258 (1983) 6410-6414.
28. [28] Tan, L.-B., Benjamin, I.J. and Clark, W.A., β-adrenergic receptor desensitisation may serve a cardioprotective role, Cardiovas. Res., 26 (1992) 608-614.
29. [29] Tomomatsu, E. and Nishi, K., Increased activity of carotid sinus baroreceptors by sympathetic stimulation and norepinephrine, Am. J. Physiol., 240 (1981) H650-H658.
30. [30] Van Giersbergen P.L.M., Palkovitis, M. and De Jong, W., Involvement of neurotransmitters in the nucleus tractus solitarii cardiovascular regulation, Physiol. Rev., 72 (1992) 789-823.